Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seresis in healthy young female volunteers
NCT02191852Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 1999
- Primary completion
- Oct 1999
01
Overview
Phase 1, open-label, single-arm trial of Seresis in oxidative stress, sponsored by Boehringer Ingelheim. Primary endpoint: Total antioxidant capacity in skin biopsies at Day 112. Started Jun 1999; status: completed.
02
Drugs
Seresis
03
Conditions
oxidative stress
Beyond the preview
Go deeper on NCT02191852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191852.